BCAX peer analysis
Bicara Therapeutics (BCAX) against its competitors: price, today's move, 1-year return and market value side by side.
BCAX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CBIO Crescent Biopharma | $13.82 | 2.07% | 5.50% | $513.37M |
| CGEM Cullinan Therapeutics | $11.70 | 3.45% | 59.18% | $752.95M |
| CMPX Compass Therapeutics | $0.85 | 12.02% | -78.75% | $153.07M |
| CNTX Context Therapeutics | $0.19 | 2.98% | -81.92% | $17.78M |
| MGNX MacroGenics | $2.33 | 0.21% | 71.69% | $148.74M |
| VRXA Veraxa Biotech | $0.95 | -0.23% | – | – |
| BCAX Bicara Therapeutics | $9.79 | 13.18% | -32.81% | $647.83M |
- BCAX's peers: CBIO (Crescent Biopharma), CGEM (Cullinan Therapeutics), CMPX (Compass Therapeutics), CNTX (Context Therapeutics), MGNX (MacroGenics), VRXA (Veraxa Biotech).
Updated 2026-11-10 04:45 UTC